Cart 0 Product Products (empty)
No products
To be determined Shipping
0,00 € Total
Prices are tax excluded
Product successfully added to your shopping cart
Quantity
Total
There are 0 items in your cart. There is 1 item in your cart.
Total products (tax excl.)
Total shipping (tax excl.) To be determined
Total (tax excl.)
Data sheet of FOXP3 polyclonal antibody
| Brand | Abnova |
| Product type | Primary antibodies |
| Reactivity | Human,Mouse |
| Host species | Rabbit |
| Applications | WB,IHC-Fr,IHC |
More info about FOXP3 polyclonal antibody
| Brand: | Abnova |
| Reference: | PAB12426 |
| Product name: | FOXP3 polyclonal antibody |
| Product description: | Rabbit polyclonal antibody raised against synthetic peptide of FOXP3. |
| Gene id: | 50943 |
| Gene name: | FOXP3 |
| Gene alias: | AIID|DIETER|IPEX|JM2|MGC141961|MGC141963|PIDX|XPID |
| Gene description: | forkhead box P3 |
| Immunogen: | A synthetic peptide corresponding to smino acids 400-431 of human FOXP3. |
| Protein accession: | Q9BZS1 |
| Form: | Liquid |
| Recommend dilutions: | Western Blot (1:1000-1:5000) Immunohistochemistry (Frozen sections) (1:50) The optimal working dilution should be determined by the end user. |
| Storage buffer: | In Tris-citrate/phosphate buffer, pH 7.0-8.0 |
| Storage instruction: | Store at 4°C. Do not freeze. |
| Quality control testing: | Antibody Reactive Against Synthetic Peptide. |
| Product type: | Primary antibodies |
| Host species: | Rabbit |
| Antigen species / target species: | Human |
| Specificity: | This antibody is specific to human FOXP3. |
| Reactivity: | Human,Mouse |
| Application image: |  |
| Application image note: | Staining of FOXP3 on Healthy thymus from a C57BL/6 mouse using FOXP3 polyclonal antibody (Cat # PAB12426). |
| Applications: | WB,IHC-Fr,IHC |
| Shipping condition: | Blue Ice |
| Publications: | Cutting edge: estrogen drives expansion of the CD4+CD25+ regulatory T cell compartment.Polanczyk MJ, Carson BD, Subramanian S, Afentoulis M, Vandenbark AA, Ziegler SF, Offner H. J Immunol. 2004 Aug 15;173(4):2227-30. |